Skip to main content
Exousia Bio, Inc. (LMMY)
OTCMKTS · Delayed Price · Currency is USD
0.0121
0.00 (0.00%)
At close: Nov 11, 2026

Exousia Bio Cash Flow Statement

Millions USD. Fiscal year is Jun - May.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '25 May '25 May '24 May '23 May '22
Net Income
-0.080.05-0.03-0.06-0
Depreciation & Amortization
00.010.010.010
Asset Writedown & Restructuring Costs
00---
Change in Accounts Receivable
0.020.01-0.01--
Change in Other Net Operating Assets
-0.08-0.080.010-
Operating Cash Flow
0.09-0-0.01-0.04-0
Operating Cash Flow Growth
2.21%----

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '25 May '25 May '24 May '23 May '22
Long-Term Debt Issued
---0-
Total Debt Issued
---00.03
Net Debt Issued (Repaid)
0.09--00.03
Issuance of Common Stock
22.050-0.030
Other Financing Activities
-0.18-0.010.010
Financing Cash Flow
21.9600.010.040.03

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '25 May '25 May '24 May '23 May '22
Net Cash Flow
-0-0-0.01-00.03

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '25 May '25 May '24 May '23 May '22
Levered Free Cash Flow
---0--
Unlevered Free Cash Flow
---0--

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '25 May '25 May '24 May '23 May '22
Change in Working Capital
0.11-0.07-00-